Suppr超能文献

生物类似药的实际应用:影响泰国医生处方决策的判别因素

Biosimilars in practice: Discriminant factors influencing prescription decisions among physicians in Thailand.

作者信息

Sooksriwong Chaoncin, Kachai Ekapong, Katchamart Wanruchada, Rojnuckarin Ponlapat, Sirachainan Ekaphop, Phodha Tuangrat

机构信息

Drug Information and Consumer Protection Center, Center of Excellence in Pharmacy Practice and Management Research, Faculty of Pharmacy, Thammasat University, Rangsit Campus, Pathum Thani, Thailand.

Division of Rheumatology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.

出版信息

PLoS One. 2025 Jul 3;20(7):e0327591. doi: 10.1371/journal.pone.0327591. eCollection 2025.

Abstract

This study aimed to assess the discriminant factors and determine the cutoff value which can predict or classify the group of prescribed and non-prescribed biosimilar among Thai physicians. The online surveys were distributed to physicians via major three medical associations in Thailand. Five psychological variables were obtained from the surveys (familiarity, attitude toward biosimilar medication, attitude toward biosimilar practice scenarios, attitude toward naming biosimilars in prescriptions, and attitude toward pricing of biosimilar). The point-based system was used to score all variables and transformed to percentage. The assumptions were tested before using discriminant function analysis (DFA). Total 82 respondents were analyzed. Data of all variables met the assumptions of DFA. Familiarity was the most influential factor to differentiate the group of physicians, followed by attitude toward biosimilar medication. The cutoff value for group differences was -0.600. The accuracy rate of discriminant function equations was 82.9% overall for the stepwise method. The study concluded that the psychological factors such as familiarity with biosimilars and attitude toward biosimilars would play a significant role to classify between prescribed and non-prescribed biosimilar groups.

摘要

本研究旨在评估判别因素,并确定能够在泰国医生中预测或区分处方生物类似药和非处方生物类似药组别的临界值。通过泰国三大主要医学协会向医生发放在线调查问卷。从调查中获取了五个心理变量(对生物类似药的熟悉程度、对生物类似药治疗的态度、对生物类似药应用场景的态度、对在处方中使用生物类似药名称的态度以及对生物类似药价格的态度)。采用基于点数的系统对所有变量进行评分,并转换为百分比。在使用判别函数分析(DFA)之前对假设进行了检验。总共对82名受访者进行了分析。所有变量的数据均符合DFA的假设。熟悉程度是区分医生组别的最具影响力因素,其次是对生物类似药治疗的态度。组间差异的临界值为-0.600。逐步法的判别函数方程总体准确率为82.9%。该研究得出结论,诸如对生物类似药的熟悉程度和对生物类似药的态度等心理因素在区分处方生物类似药组和非处方生物类似药组方面将发挥重要作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be36/12225845/93ca08c1638a/pone.0327591.g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验